| Abstrakt: |
Lutein, as a carotenoid with strong antioxidant capacity and an important component of macular pigment in the retina, has wide applications in pharmaceutical, food, feed, and cosmetics industries. Besides extraction from plant and algae, microbial fermentation using engineered cell factories to produce lutein has emerged as a promising route. However, intra‐pathway competition between the lycopene cyclases and the conflict between cell growth and production are two major challenges. In our previous study, de novo synthesis of lutein had been achieved in Saccharomyces cerevisiae by dividing the pathway into two stages (δ‐carotene formation and conversion) using temperature as the input signal to realize sequential cyclation of lycopene. However, lutein production was limited to microgram level, which is still too low to meet industrial demand. In this study, a dual‐signal hierarchical dynamic regulation system was developed and applied to divide lutein biosynthesis into three stages in response to glucose concentration and culture temperature. By placing the genes involved in δ‐carotene formation under the glucose‐responsive ADH2 promoter and genes involved in the conversion of δ‐carotene to lutein under temperature‐responsive GAL promoters, the growth‐production conflict and intra‐pathway competition were simultaneously resolved. Meanwhile, the rate‐limiting lycopene ε‐cyclation and carotene hydroxylation reactions were improved by screening for lycopene ε‐cyclase with higher activity and fine tuning of the P450 enzymes and their redox partners. Finally, a lutein titer of 19.92 mg/L (4.53 mg/g DCW) was obtained in shake‐flask cultures using the engineered yeast strain YLutein‐3S‐6, which is the highest lutein titer ever reported in heterologous production systems. [ABSTRACT FROM AUTHOR] |
Plný text